Trial NCT04425629
Publication Weinreich D (2), medRxiv, 2021 (preprint)
Dates: 2020-09-24 to 2021-01-17
Funding: Mixed (Regeneron Pharmaceuticals, Inc.; Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority)
Conflict of interest: Yes